文摘
Anti-cancer effects of a newly-synthesized palladium(II) complex, [Pd(sac)(terpy)](sac)¡¤4H2O (sac?=?saccharinate, and terpy?=?2,2¡ä:6¡ä,2¡å-terpyridine), were tested against human breast cancer cell lines, MCF-7 and MDA-MB-231. The Pd complex had a strong anti-growth effect in a dose- and time-dependent manner in?vitro. This effect was also confirmed by the experiment performed on Balb/c mice in?vivo. The IC50 values were 0.09?¦ÌM for MDA-MB-231 and 3.05?¦ÌM for MCF-7. It was also very effective in disrupting the formation of MDA-MB-231 tubules on matrigel, indicative of a putative anti-invasive activity. It induced apoptosis via the cell death genes of DR4 and DR5. In conclusion, this newly-synthesized Pd (II) complex represents a potentially active novel drug for the breast cancer treatment.